Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
clinical trials
fda
life sciences
national
national blog main
san francisco blog main
san francisco top stories
abaloparatide
alder biopharmaceuticals
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
david rind
detroit blog main
detroit top stories
eli lilly
episodic migraine
eptinezumab
erenumab
europe blog main
europe top stories
european commission
food and drug administration
fremanezumab
galcanezumab
indiana blog main
indiana top stories
institute for clinical and economic review
migraine research foundation
migraines
national top stories
new york blog main
new york top stories
novartis
osteoporosis
What
amgen
3
×
drug
approval
class
developed
new
nod
amgen’s
called
candidates
carries
companies
conducted
crippling
days
erenumab
europe
european
extra
fda
fewer
gets
head
headaches
heart
late
led
lot
marketing
means
medications
medicine
medicines
migraine
migraine.the
migraines
month
novartis
osteoporosis
pain
Language
unset
Current search:
amgen
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@theverge.com
7 years ago
This new drug promises fewer days a month with migraines
